Export

ATC codes: H02AB06
Indication
Malignant neoplasms of prostate ICD11 code: 2D32.Z
INN
Prednisolone
Medicine type
Chemical agent
List type
Complementary
Formulations
Oral > Solid: 5 mg ; 25 mg
EML status history
First added in 2019 (TRS 1021)
Sex
Male
Age
Adolescents and adults
Therapeutic equivalence
Medicines within the same pharmacological class can be used
Patent information
Patents have expired in most jurisdictions
Tags
Wikipedia
Summary of evidence and Expert Committee recommendations
The listing for prednisolone on the EML was extended to include the new indication of metastatic castration-resistant prostate cancer. Refer to the 2019 recommendation for abiraterone for more information.